Journal
NUCLEIC ACIDS RESEARCH
Volume 38, Issue 6, Pages 1997-2005Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkp1120
Keywords
-
Categories
Funding
- Laboratory Directed Research and Development Award at Brookhaven National Laboratory
- Low Dose Radiation Research Program of the Office of Biological and Environmental Research program of the US Department of Energy
- National Institutes of Health [U01-AI56480]
- U. S. Department of Energy and National Institutes of Health [U01-AI56480]
Ask authors/readers for more resources
The Escherichia coli McrA protein, a putative C-5-methylcytosine/C-5-hydroxyl methylcytosine-specific nuclease, binds DNA with symmetrically methylated HpaII sequences (Cm5CGG), but its precise recognition sequence remains undefined. To determine McrA's binding specificity, we cloned and expressed recombinant McrA with a C-terminal StrepII tag (rMcrA-S) to facilitate protein purification and affinity capture of human DNA fragments with m5C residues. Sequence analysis of a subset of these fragments and electrophoretic mobility shift assays with model methylated and unmethylated oligonucleotides suggest that N(Y > R) m5CGR is the canonical binding site for rMcrA-S. In addition to binding HpaII-methylated double-stranded DNA, rMcrA-S binds DNA containing a single, hemimethylated HpaII site; however, it does not bind if A, C, T or U is placed across from the m5C residue, but does if I is opposite the m5C. These results provide the first systematic analysis of McrA's in vitro binding specificity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available